SummaryAdvanced heart failure (HF) is sometimes complicated with brain impairment because of a microthrombosis caused by decreased left ventricular contraction or reduced brain circulation. Some patients may recover after left ventricular assist device (LVAD) implantation. However, little is known about the perioperative therapeutic strategy in patients suffering from such complications, particularly from a cardiac rehabilitation viewpoint. We report on a 58-year-old male patient with a previous history of poliomyelitis and a light paralysis in the left upper extremity, who suffered left hemiplegia with no evidence of stroke after hemodynamic deterioration. The combination therapy of perioperative cardiac rehabilitation and LVAD therapy improved his left hemiplegia as well as activities of daily living, and the patient was discharged on foot on postoperative day 72 after briefing the family on LVAD home management. Early initiation of cardiac rehabilitation before LVAD implantation may be a key for the smooth discharge and resocialization of patients suffering from brain impairment complicated with advanced HF. (Int Heart J 2016; 57: 766-768) Key words: Cardiomyopathy, Stage D, Mechanical circulatory support A s one of the end-organ dysfunctions, the complication of cognitive dysfunction is sometimes seen in patients with advanced heart failure (HF) because of a microembolism caused by decreased left ventricular contraction or reduced brain circulation.1-5) Improvement of such brain impairment is strongly expected after left ventricular assist device (LVAD) implantation because resocialization is encouraged in such LVAD patients. 6) However, little is known about the perioperative therapeutic strategy for brain impairment, particularly from the viewpoint of cardiac rehabilitation.Here we report a patient who suffered left hemiplegia after hemodynamic deterioration despite no evidence of stroke and received early cardiac rehabilitation before LVAD implantation.
Case ReportPatient presentation: A 58-year-old male patient (height 173 cm, weight 64 kg) with stage D HF due to dilated cardiomyopathy was admitted to our hospital to consider a heart transplant (HTx) listing and LVAD treatment. His HF had progressed gradually, and he had experienced repeated admissions because of a recurrence of HF despite guideline-directed medical therapy along with implantable cardioversion therapy.7) On admission, his New York Heart Association class was IV, and his plasma B-type natriuretic peptide level was 630 pg/mL. Transthoracic echocardiography showed that the left ventricular diastolic diameter was 74 mm, the left ventricular ejection fraction was 18%, and there was severe mitral regurgitation and moderate tricuspid regurgitation. After hospitalization, cardiac low output syndrome progressed despite continuous intravenous inotrope infusion. He eventually underwent LVAD implantation (HeartMate II, Thoratec, Pleasanton, CA) on day 33, 9 days after preoperative intra-aortic balloon pumping (IABP) support. After the initiation ...